Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of hemostatic efficacy and cytotoxicity of three ferric subsulfate- and chitosan-based styptics in different formulations using a rat tail bleeding model

  • Byun, Jae-Young (Department of Veterinary Surgery, College of Veterinary Medicine, Konkuk University) ;
  • Lee, Soojung (Regeniks Co., Ltd.) ;
  • Lee, Jeong Ik (Regeniks Co., Ltd.) ;
  • Yoon, Hun-Young (Department of Veterinary Surgery, College of Veterinary Medicine, Konkuk University)
  • Received : 2018.05.18
  • Accepted : 2018.07.12
  • Published : 2018.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

This study was conducted to compare the hemostatic efficacy of three ferric subsulfate- and chitosan-based styptics as a powder and a gel containing ferric subsulfate and chitosan (FSC-PO and FSC-G, respectively) and a soaked pad containing ferric subsulfate and lidocaine (FSL-SP) using a rat tail bleeding model. The cytotoxicity of the styptics against L-929 mouse fibroblasts was also evaluated using a cell counting kit-8 assay. Four groups of 10 rats each were assigned to the three different styptics and a non-treated control groups. Rat tail tips were transected, after which styptics were applied with pressure. The wounds were observed for hemostasis for 3 min, then irrigated with saline to check for recurrent hemorrhage. L-929 mouse fibroblasts were exposed to extracts of the styptics (100 mg/mL) and their dilutions (1:10, 1:100, and 1:1,000). FSC-PO and FSC-G more effectively controlled initial hemorrhage than FSL-SP (p = 0.033). Additionally, FSC-PO and FSC-G more effectively maintained hemostasis than the control group (p = 0.02 and p < 0.01, respectively). However, all styptics showed enhanced cytotoxicity against L-929 cells in a dose-dependent manner. Therefore, although FSC-PO and FSC-G would be recommended to control hemorrhage, the benefits of styptics must be balanced against the clinical significance of their cytotoxicity.

Keywords

References

  1. Alam HB, Uy GB, Miller D, Koustova E, Hancock T, Inocencio R, Anderson D, Llorente O, Rhee P. Comparative analysis of hemostatic agents in a swine model of lethal groin injury. J Trauma 2003, 54, 1077-1082. https://doi.org/10.1097/01.TA.0000068258.99048.70
  2. Anitha A, Rani VVD, Krishna R, Sreeja V, Selvamurugan N, Nair SV, Tamura H, Jayakumar R. Synthesis, characterization, cytotoxicity and antibacterial studies of chitosan, Ocarboxymethyl and N,O-carboxymethyl chitosan nanoparticles. Carbohydr Polym 2009, 78, 672-677. https://doi.org/10.1016/j.carbpol.2009.05.028
  3. Armstrong RB, Nichols J, Pachance J. Punch biopsy wounds treated with Monsel's solution or a collagen matrix. A comparison of healing. Arch Dermatol 1986, 122, 546-549. https://doi.org/10.1001/archderm.1986.01660170076023
  4. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982, 70, 550-557. https://doi.org/10.1172/JCI110647
  5. Brooks J. Coagulopathies and thrombosis. In: Ettinger SJ, Felman EC (eds.). Textbook of Veterinary Internal Medicine: Disease of the Dog and Cat. 5th ed. pp. 1829-1841, WB Saunders, Philadelphia, 2000.
  6. Broze GJ Jr, Yin ZF, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost 2001, 85, 747-748. https://doi.org/10.1055/s-0037-1615666
  7. Chan MW, Schwaitzberg SD, Demcheva M, Vournakis J, Finkielsztein S, Connolly RJ. Comparison of poly-N-acetyl glucosamine (P-GlcNAc) with absorbable collagen (Actifoam), and fibrin sealant (Bolheal) for achieving hemostasis in a swine model of splenic hemorrhage. J Trauma 2000, 48, 454-458. https://doi.org/10.1097/00005373-200003000-00013
  8. Chang Y, Yang ST, Liu JH, Dong E, Wang Y, Cao A, Liu Y, Wang H. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 2011, 200, 201-210. https://doi.org/10.1016/j.toxlet.2010.11.016
  9. Chu CR, Izzo NJ, Coyle CH, Papas NE, Logar A. The in vitro effects of bupivacaine on articular chondrocytes. J Bone Joint Surg Br 2008, 90, 814-820.
  10. Donahue SM, Otto CM. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care (San Antonio) 2005, 15, 9-16. https://doi.org/10.1111/j.1476-4431.2005.04025.x
  11. Epstein E, Maibach HI. Monsel's solution. History, chemistry and efficacy. Arch Dermatol 1964, 90, 226-228. https://doi.org/10.1001/archderm.1964.01600020094022
  12. Fischer DE. Tissue management: a new solution to an old problem. Gen Dent 1987, 35, 178-182.
  13. Fukasawa M, Abe H, Masaoka T, Orita H, Horikawa H, Campeau JD, Washio M. The hemostatic effect of deacetylated chitin membrane on peritoneal injury in rabbit model. Surg Today 1992, 22, 333-338. https://doi.org/10.1007/BF00308742
  14. Howe N, Cherpelis B. Obtaining rapid and effective hemostasis. Part I. Update and review of topical hemostatic agents. J Am Acad Dermatol 2013, 69, 659.e1-659.e17. https://doi.org/10.1016/j.jaad.2013.07.014
  15. Irwin W, Fontaine E, Agnolucci L, Penzo D, Betto R, Bortolotto S, Reggiani C, Salviati G, Bernardi P. Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem 2002, 277, 12221-12227. https://doi.org/10.1074/jbc.M108938200
  16. International Organization for Standardization (ISO). ISO 10993-5:2009. Biological evaluation of medical devices-Part 5: Tests for in vitro cytotoxicity. ISO, Geneva, 2009.
  17. Jacobs TF, Vansintjan PS, Roels N, Herregods SS, Verbruggen G, Herregods LL, Almqvist KF. The effect of Lidocaine on the viability of cultivated mature human cartilage cells: an in vitro study. Knee Surg Sports Traumatol Arthrosc 2011, 19, 1206-1213. https://doi.org/10.1007/s00167-011-1420-5
  18. Jansen T, Wallin RF. A practical guide to ISO 10993-12: sample preparation and reference materials. North American Science Associates, Northwood, 1998.
  19. Jeansonne BG, Boggs WS, Lemon RR. Ferric sulfate hemostasis: effect on osseous wound healing. II. With curettage and irrigation. J Endod 1993, 19, 174-176. https://doi.org/10.1016/S0099-2399(06)80682-5
  20. Jiao G, He X, Li X, Qiu J, Xu H, Zhang N, Liu S. Limitations of MTT and CCK-8 assay for evaluation of graphene cytotoxicity. RSC Adv 2015, 5, 53240-53244. https://doi.org/10.1039/C5RA08958A
  21. Kheirabadi BS, Edens JW, Terrazas IB, Estep JS, Klemcke HG, Dubick MA, Holcomb JB. Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine. J Trauma 2009, 66, 316-328. https://doi.org/10.1097/TA.0b013e31819634a1
  22. Klokkevold PR, Fukayama H, Sung EC, Bertolami CN. The effect of chitosan (poly-N-acetyl glucosamine) on lingual hemostasis in heparinized rabbits. J Oral Maxillofac Surg 1999, 57, 49-52. https://doi.org/10.1016/S0278-2391(99)90632-8
  23. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998, 60, 619-642. https://doi.org/10.1146/annurev.physiol.60.1.619
  24. Kunio NR, Riha GM, Watson KM, Differding JA, Schreiber MA, Watters JM. Chitosan based advanced hemostatic dressing is associated with decreased blood loss in a swine uncontrolled hemorrhage model. Am J Surg 2013, 205, 505-510. https://doi.org/10.1016/j.amjsurg.2013.01.014
  25. Kuwahara RT, Craig SR, Amonette R. More on Monsel's solution. Dermatol Surg 2000, 26, 979-980. https://doi.org/10.1046/j.1524-4725.2000.026010979.x
  26. Larson PO. Topical hemostatic agents for dermatologic surgery. J Dermatol Surg Oncol 1988, 14, 623-632. https://doi.org/10.1111/j.1524-4725.1988.tb03390.x
  27. Lemon RR, Steele PJ, Jeansonne BG. Ferric sulfate hemostasis: effect on osseous wound healing. I. Left in situ for maximum exposure. J Endod 1993, 19, 170-173. https://doi.org/10.1016/S0099-2399(06)80681-3
  28. Lonnroth EC, Dahl JE. Cytotoxicity of liquids and powders of chemically different dental materials evaluated using dimethylthiazol diphenyltetrazolium and neutral red tests. Acta Odontol Scand 2003, 61, 52-56. https://doi.org/10.1080/ode.61.1.52.56
  29. Miller DT, Roque DM, Santin AD. Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents. Am J Obstet Gynecol 2015, 212, 725-735. https://doi.org/10.1016/j.ajog.2014.12.029
  30. Millner R, Lockhart AS, Marr R. Chitosan arrests bleeding in major hepatic injuries with clotting dysfunction: an in vivo experimental study in a model of hepatic injury in the presence of moderate systemic heparinisation. Ann R Coll Surg Engl 2010, 92, 559-561. https://doi.org/10.1308/003588410X12699663903593
  31. Miyazaki T, Kobayashi S, Takeno K, Yayama T, Meir A, Baba H. Lidocaine cytotoxicity to the bovine articular chondrocytes in vitro: changes in cell viability and proteoglycan metabolism. Knee Surg Sports Traumatol Arthrosc 2011, 19, 1198-1205. https://doi.org/10.1007/s00167-010-1369-9
  32. Palm MD, Altman JS. Topical hemostatic agents: a review. Dermatol Surg 2008, 34, 431-445.
  33. Putnam KP, Bombick DW, Doolittle DJ. Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate. Toxicol In Vitro 2002, 16, 599-607. https://doi.org/10.1016/S0887-2333(02)00050-4
  34. Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res 1997, 34, 21-28. https://doi.org/10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
  35. Sawchuk WS, Friedman KJ, Manning T, Pinnell SR. Delayed healing in full-thickness wounds treated with aluminum chloride solution: a histologic study with evaporimetry correlation. J Am Acad Dermatol 1986, 15, 982-989. https://doi.org/10.1016/S0190-9622(86)70261-2
  36. Spitzer M, Chernys AE. Monsel's solution-induced artifact in the uterine cervix. Am J Obstet Gynecol 1996, 175, 1204-1207. https://doi.org/10.1016/S0002-9378(96)70029-7
  37. Wagner WR, Pachence JM, Ristich J, Johnson PC. Comparative in vitro analysis of topical hemostatic agents. J Surg Res 1996, 66, 100-108. https://doi.org/10.1006/jsre.1996.0379
  38. Whalen J, Tuman KJ. Monitoring hemostasis. Int Anesthesiol Clin 1996, 34, 195-213.